Copenhagen is a significant contender to host the European Medicines Agency. In this blog post we look at Copenhagen and carry out a brief SWOT analysis of its capacity to host the EMA. In the second of our SWOT analysis pieces in our Brexit series, we look at Copenhagen’s capacity to host the European Medicines Agency. Denmark must be seen as one of the leading contenders in the competition to host the EMA. The Scandinavian country is frequently cited in studies highlighting quality of life, healthcare systems, educational standards and public services. Furthermore, it has a significant life sciences sector and it is home to companies such as Novo Nordisk, LEO Pharma and many others.